Radiopharmaceutical Batch Dilution for Consistent Activity Timing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for producing radiopharmaceuticals face challenges in maintaining consistent radioactivity and chemical composition across multiple applications due to the short half-life of radionuclides, leading to complex and costly production processes that either require frequent reconstitution or limited availability.

Innovation Solution

A method involving a radionuclide-containing concentrate is prepared to produce batches with identical activity at different application times, using a bulk solution and dilution process to maintain consistent radioactivity levels, facilitated by a fluidic system with adjustable components.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If radiopharmaceuticals are produced locally on a patient-oriented basis, then consistent activity at different application times is achieved, but production complexity and cost increase

Engineering Contradiction:
Improveactivity consistencyVSAvoidproduction process complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The concentrate is prepared in advance with a calculated initial activity that accounts for radioactive decay to the latest application time (ART+4). This preliminary calculation and preparation of the bulk solution eliminates the need for complex real-time adjustments during production, while ensuring consistent activity across multiple application times.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The method changes the activity parameter of the bulk solution by diluting with a non-radioactive diluting solution containing all other required components. This allows the same bulk solution to be used for multiple batches with different activity levels corresponding to different application times, simplifying the production process while maintaining precision.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If a single bulk solution is used for multiple batches, then productivity increases, but maintaining consistent composition across different application times becomes difficult

Engineering Contradiction:
Improvebatch production efficiencyVSAvoidradioactivity consistency
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The bulk solution's activity parameter is systematically adjusted by adding varying amounts of diluting solution to create different batches. The diluting solution contains all non-radioactive components at correct concentrations, so only the radioactivity parameter changes between batches, maintaining composition stability while enabling high productivity.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The diluting solution acts as an intermediary that allows controlled reduction of activity in the bulk solution without affecting other compositional parameters. It serves as a vehicle to transfer the radionuclide-labeled product from high concentration to lower concentrations suitable for different application times.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Manufacturing precision

If frequent reconstitution is performed to maintain activity levels, then activity consistency is improved, but manufacturing time and cost increase

Engineering Contradiction:
Improveactivity accuracyVSAvoidmanufacturing time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

All non-radioactive components are pre-mixed into the bulk solution at the correct concentrations before radionuclide addition. This preliminary preparation eliminates the need for frequent reconstitution operations, as the bulk solution is ready for multiple batch productions with only dilution required to adjust activity levels.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The bulk solution serves as a continuous source for multiple batches over several days. Instead of discrete reconstitution operations for each batch, the system maintains a continuous supply of radionuclide-labeled product that can be diluted and filled repeatedly, significantly reducing manufacturing time and operations.

Inventive Principle:
Principle #20Continuity of useful action

4Adaptability or versatility

If multiple filling units are used to produce batches for different application times, then product availability improves, but device complexity and cost increase

Engineering Contradiction:
Improveapplication time coverageVSAvoidfilling system complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

A single filling unit is designed to handle multiple application times by varying the dilution ratio of the bulk solution. The same filling device can produce batches for ART+1, ART+2, ART+3, and ART+4 by adjusting the amount of diluting solution added, eliminating the need for multiple specialized filling units while maintaining full versatility.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the production of radiopharmaceuticals with consistent activity and composition across various application times, reducing manufacturing costs and increasing efficiency by eliminating the need for multiple filling units and ensuring homogeneous quality control.

Implementation Method 1

due to their short half-life or lifespan, especially in the case of diagnostic compounds

Methodology Applied
Scientific EffectRadioactive decay: Radioactive Decay

Data Source

PatentUS12491273B2Radiopharmaceuticals at different activity reference times
Publication Date: 2025.12.09 ITM ISOTOPE TECH MUNICH SE
  • US12491273B2 patent drawing
  • US12491273B2 patent drawing
  • US12491273B2 patent drawing

AI summary

A method and an apparatus for producing radionuclide-containing products having substantially the identical desired activity of radioactivity at different times of application, with respect to a given calibration time. The method according to the invention allows to ensure a consistent composition of the desired radionuclide-labeled pharmaceutical at all times of application within the shelf life through a single manufacturing process. With the present invention it is possible, for example, to provide [n.c.a. Lu-177]Lu-DOTATOC on each working day of the week with constant activity at the respective time of application in a single manufacturing step.